Corcept Therapeutics | CORT - EPS Earnings Per Share


Corcept Therapeutics reported $0.16 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.38 0.26 Feb/18 2026
FY2025Q3 Sep/2025 0.16 0.17 0.41 Nov/04 2025
FY2025Q2 Jun/2025 0.29 0.38 0.32 Jul/31 2025
FY2025Q1 Mar/2025 0.17 0.15 0.25 May/05 2025
FY2024Q4 Dec/2024 0.26 0.38 0.28 Feb/26 2025




Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
ANI Pharmaceuticals USD 2.04 0.24 Sep/2025
Ardelyx USD 0 0.08 Sep/2025
Aurora Cannabis CAD -1 0.73 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Corcept Therapeutics USD 0.16 0.13 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Pacira USD 0.7 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
TG Therapeutics USD 2.43 2.26 Sep/2025